Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2026-02-20 @ 5:56 PM
Study NCT ID:
NCT03187756
Status:
TERMINATED
Last Update Posted:
2020-03-27
First Post:
2017-06-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Nonmyeloablative Peripheral Blood Stem Cell Transplant With High-dose Posttransplantation Cyclophosphamide in Hematopoietic Malignancies Including Those That Are Challenging to Engraft
Sponsor:
NYU Langone Health
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-02
Start Date Type:
ACTUAL
Primary Completion Date:
2018-12-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-18
Completion Date Type:
ACTUAL
First Submit Date:
2017-06-02
First Submit QC Date:
None
Study First Post Date:
2017-06-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-02-11
Results First Submit QC Date:
None
Results First Post Date:
2020-03-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-03-16
Last Update Post Date:
2020-03-27
Last Update Post Date Type:
ACTUAL